Metraipolis › archive › dc_ed0d4437bc65

New oncology trial designs and equipoise: Commentary on Heynemann et al — Europe PMC PMID:42723605

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42723605
DOI
10.1177/17407745261471455
License (as archived)
solo-consultazione
Archived
2026-10-10T03:51:17.628Z
SHA-256 of the archived text
36c568063ab84d4f9b0f32053eaad62cf808d9367aa98d79a0c296e5e649fb5b
Stable URL of this page
https://metraipolis.com/documento/dc_ed0d4437bc65

How to cite

New oncology trial designs and equipoise: Commentary on Heynemann et al — Europe PMC PMID:42723605 — Europe PMC (en), https://europepmc.org/article/MED/42723605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed0d4437bc65 (Metraipolis archive dc_ed0d4437bc65, sha256 36c568063ab84d4f9b0f32053eaad62cf808d9367aa98d79a0c296e5e649fb5b)
BibTeX
@misc{dced0d4437bc65,
  title = {New oncology trial designs and equipoise: Commentary on Heynemann et al — Europe PMC PMID:42723605},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42723605},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed0d4437bc65; sha256 36c568063ab84d4f9b0f32053eaad62cf808d9367aa98d79a0c296e5e649fb5b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42723605. Agents can read the archived copy with the MCP tool read_document.